Thyrocare Technologies Limited
NSE:THYROCARE.NS
978 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | ||||||||||||
Net Income
| 707.6 | 874.1 | 2,279 | 1,525.4 | 1,464.9 | 1,380.6 | 1,449.94 | 1,094.15 | 818.03 | 665.39 | 461.56 | 568.19 |
Depreciation & Amortization
| 470.1 | 387.1 | 338.7 | 302.8 | 319.1 | 261.7 | 201 | 180.47 | 182.37 | 128.65 | 63.62 | 33.15 |
Deferred Income Tax
| 0 | -247.4 | -731.2 | -506.7 | -474.4 | -660.6 | -640.24 | -443.78 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 166.7 | 211.7 | 23.2 | 16.8 | 20 | 19.3 | 17.1 | 24.63 | 17.73 | 8.18 | 0 | 0 |
Change In Working Capital
| 301.6 | 57.9 | -792.2 | -179 | 335.2 | -5.8 | 22.81 | 41 | 8.66 | -168.61 | -27.28 | 49.42 |
Accounts Receivables
| 328.2 | -14.3 | -587.2 | -285.6 | -60.3 | -27.9 | -37.13 | 5.15 | -24.67 | 0.01 | -15.73 | 1.01 |
Inventory
| -198.5 | -31.4 | -11.7 | -27.4 | -25.4 | -10.3 | -25.56 | -37.81 | -33.51 | -10.51 | -10.5 | -1.49 |
Accounts Payables
| 161.2 | 74.2 | -84.8 | 31.5 | 143.5 | 9.1 | -1.33 | -5.43 | 12.11 | 0 | 0 | 0 |
Other Working Capital
| 10.7 | 29.4 | -108.5 | 102.5 | 277.4 | 23.3 | 48.37 | 78.81 | 42.17 | -158.1 | -1.05 | 49.9 |
Other Non Cash Items
| 814 | 9.7 | 16.6 | 1 | 11.5 | 7.9 | 19.7 | -2.03 | -331.05 | -280.75 | -35.51 | -191.53 |
Operating Cash Flow
| 1,644 | 1,293.1 | 1,134.1 | 1,160.3 | 1,676.3 | 1,003.1 | 1,070.31 | 894.44 | 678.01 | 344.68 | 462.39 | 459.23 |
Investing Activities: | ||||||||||||
Investments In Property Plant And Equipment
| -615.9 | -436.5 | -378.3 | -282.6 | -99 | -402.5 | -436.5 | -363.63 | -144.2 | -99.95 | -146.99 | -687.98 |
Acquisitions Net
| 19.3 | 34 | 42.5 | 42.5 | -95.9 | -255.3 | -100 | 50.45 | 0.75 | -591.49 | 0 | 0 |
Purchases Of Investments
| -314 | -1,921.2 | -1,730 | -1,361.1 | -1,333.4 | -1,151.5 | -914.27 | -1,227.67 | -1,064.44 | -1,270 | 0 | 0 |
Sales Maturities Of Investments
| 0 | 1,932.5 | 1,593.5 | 1,042.1 | 1,429.3 | 1,406.8 | 979.17 | 1,125.73 | 998.67 | 1,773.52 | 0 | 0 |
Other Investing Activites
| -297 | 1.3 | 236.6 | 56.8 | 108.5 | 286.6 | 39.41 | -0.01 | 33.22 | 8.24 | -372.14 | -194.74 |
Investing Cash Flow
| -910.6 | -389.9 | -235.7 | -502.3 | 9.5 | -115.9 | -432.19 | -415.13 | -176.75 | -179.68 | -519.13 | -882.72 |
Financing Activities: | ||||||||||||
Debt Repayment
| -216 | -22.5 | -53.8 | -25 | -43.9 | -17.1 | 0 | -10 | 0 | 0 | 0 | 0 |
Common Stock Issued
| 0.2 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0 | 0 | 0 | 0.34 | 0 | 0 |
Common Stock Repurchased
| 0 | -55.3 | -53.8 | 24.8 | 43.9 | -630 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| -952.7 | -793.5 | -793.1 | -528.4 | -1,590 | -268.6 | -537.24 | -402.93 | -379.02 | -228.78 | 0 | 0 |
Other Financing Activities
| 12.1 | 9.3 | 6.3 | -87.4 | -328.6 | -21 | -101.52 | -72.04 | -70.54 | -38.55 | 0 | 8.11 |
Financing Cash Flow
| -818.1 | -861.8 | -894.1 | -615.7 | -1,647.8 | -936.3 | -638.76 | -484.97 | -449.56 | -228.44 | 0 | 8.11 |
Other Information: | ||||||||||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0.1 | 2.5 | 0 | 0 | -0.01 | 0 | 0 | 0 | 586.31 |
Net Change In Cash
| 221.2 | 41.4 | 4.3 | 42.4 | 38 | -49.1 | -0.64 | -5.67 | 51.7 | -63.44 | -56.73 | 170.93 |
Cash At End Of Period
| 398.9 | 177.7 | 136.3 | 132 | 87.1 | 49.1 | 98.2 | 96.78 | 102.45 | 50.76 | 114.2 | 170.93 |